Companies / Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc.
Company
Monte Rosa Therapeutics develops medicines by degrading proteins, including those previously considered undruggable, to treat various diseases.
Monte Rosa Therapeutics, Inc. has 6 investors on file, among them Aisling Capital, Amzak Health and Avoro Capital Advisors. Its site was last checked 6 Nov 2026: site answers.
Investors
6 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Investor | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Monte Rosa Therapeutics, Inc. and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Aisling Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/monterosatx.com/investors
# also
GET /v1/companies/monterosatx.com
GET /v1/companies/monterosatx.com/news